Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Brain ; 131(Pt 1): 109-19, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18056160

ABSTRACT

Alzheimer's disease has long been known to involve cholinergic deficits, but the linkage between cholinergic gene expression and the Alzheimer's disease amyloid pathology has remained incompletely understood. One known link involves synaptic acetylcholinesterase (AChE-S), shown to accelerate amyloid fibrils formation. Here, we report that the 'Readthrough' AChE-R splice variant, which differs from AChE-S in its 26 C-terminal residues, inversely exerts neuroprotective effects from amyloid beta (Abeta) induced toxicity. In vitro, highly purified AChE-R dose-dependently suppressed the formation of insoluble Abeta oligomers and fibrils and abolished Abeta toxicity to cultured cells, competing with the prevalent AChE-S protein which facilitates these processes. In vivo, double transgenic APPsw/AChE-R mice showed lower plaque burden, fewer reactive astrocytes and less dendritic damage than single APPsw mice, inverse to reported acceleration of these features in double APPsw/AChE-S mice. In hippocampi from Alzheimer's disease patients (n = 10), dentate gyrus neurons showed significantly elevated AChE-R mRNA and reduced AChE-S mRNA. However, immunoblot analyses revealed drastic reductions in the levels of intact AChE-R protein, suggesting that its selective loss in the Alzheimer's disease brain exacerbates the Abeta-induced damages and revealing a previously unforeseen linkage between cholinergic and amyloidogenic events.


Subject(s)
Acetylcholinesterase/pharmacology , Alzheimer Disease/metabolism , Amyloid beta-Peptides/biosynthesis , Acetylcholinesterase/genetics , Acetylcholinesterase/physiology , Adult , Aged , Aged, 80 and over , Alternative Splicing , Alzheimer Disease/enzymology , Alzheimer Disease/pathology , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/drug effects , Animals , Astrocytes/pathology , Brain/metabolism , Brain/pathology , Dendrites/pathology , Dose-Response Relationship, Drug , Female , Gene Expression Regulation, Enzymologic , Hippocampus/enzymology , Humans , Male , Mice , Mice, Transgenic , Middle Aged , RNA, Messenger/genetics , Recombinant Proteins/pharmacology , Tumor Cells, Cultured
2.
Cell Stress Chaperones ; 10(4): 329-39, 2005.
Article in English | MEDLINE | ID: mdl-16333986

ABSTRACT

When massively expressed in bacteria, recombinant proteins often tend to misfold and accumulate as soluble and insoluble nonfunctional aggregates. A general strategy to improve the native folding of recombinant proteins is to increase the cellular concentration of viscous organic compounds, termed osmolytes, or of molecular chaperones that can prevent aggregation and can actively scavenge and convert aggregates into natively refoldable species. In this study, metal affinity purification (immobilized metal ion affinity chromatography [IMAC]), confirmed by resistance to trypsin digestion, was used to distinguish soluble aggregates from soluble nativelike proteins. Salt-induced accumulation of osmolytes during induced protein synthesis significantly improved IMAC yields of folding-recalcitrant proteins. Yet, the highest yields were obtained with cells coexpressing plasmid-encoded molecular chaperones DnaK-DnaJ-GrpE, ClpB, GroEL-GroES, and IbpA/B. Addition of the membrane fluidizer heat shock-inducer benzyl alcohol (BA) to the bacterial medium resulted in similar high yields as with plasmid-mediated chaperone coexpression. Our results suggest that simple BA-mediated induction of endogenous chaperones can substitute for the more demanding approach of chaperone coexpression. Combined strategies of osmolyte-induced native folding with heat-, BA-, or plasmid-induced chaperone coexpression can be thought to optimize yields of natively folded recombinant proteins in bacteria, for research and biotechnological purposes.


Subject(s)
Benzyl Alcohol/pharmacology , Escherichia coli Proteins/chemistry , Escherichia coli/drug effects , Molecular Chaperones/metabolism , Protein Folding , Recombinant Fusion Proteins/chemistry , Animals , Chaperonin 10/metabolism , Chaperonin 60/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Gene Expression Regulation, Bacterial , Molecular Chaperones/genetics , Osmolar Concentration , Protein Conformation , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
3.
Eur J Neurosci ; 4(12): 1249-1256, 1992.
Article in English | MEDLINE | ID: mdl-12106388

ABSTRACT

The process of regulated secretion in PC-12 cells is tightly coupled to calcium entry, which is absolutely dependent on extracellular Ca2+([Ca2+]ex). Tunicamycin treatment of the cells dissociated depolarization-triggered Ca2+ influx from depolarization (high K+)-induced transmitter release into two distinct and independent phases. Deplarization-evoked Ca2+ influx was not affected by tunicamycin treatment (1 microg/ml, 72 h), whereas depolarization-evoked transmitter release was strongly inhibited (> 60%), suggesting at least a two-step process, and the participation of glycosylated protein(s) in the actual fusion/secretion step. Similarly, bradykinin-mediated transmitter release was linearly related to and absolutely dependent on Ca2+ entry, and was inhibited by tunicamycin treatment (> 80%), whereas bradykinin-evoked Ca2+ entry was not impaired, indicating that glycosylated protein(s) are essential for bradykinin-evoked release at a step subsequent to Ca2+ influx. The heavily glycosylated alpha2 subunit of the dihydropyridine-sensitive channel, which was used to monitor tunicamycin inhibition of glycosylation, was not expressed in the tunicamycin-treated cells, as shown by Western blot analysis. This observation allowed us to conclude that the alpha1 subunit of the heteromeric dihydropyridine voltage-sensitive Ca2+ channel, which is responsible for Ca2+ entry, is also fully functional when not assembled with its corresponding alpha2 subunit. The molecular properties of the alpha2 subunit, whose role in the complex structure of the channel is not yet understood, are shown for the first time for the L-type Ca2+ channel of PC-12 cells. Similar to cardiac and skeletal muscle cells, the alpha2 subunit appears to be a glycosylated polypeptide of molecular weight 170 kD and to display a characteristic mobility shift to 140 kD under reducing conditions.

4.
PLoS One ; 3(9): e3108, 2008 Sep 01.
Article in English | MEDLINE | ID: mdl-18769671

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) involves loss of cholinergic neurons and Tau protein hyper-phosphorylation. Here, we report that overexpression of an N-terminally extended "synaptic" acetylcholinesterase variant, N-AChE-S is causally involved in both these phenomena. METHODOLOGY AND PRINCIPAL FINDINGS: In transfected primary brain cultures, N-AChE-S induced cell death, morphological impairments and caspase 3 activation. Rapid internalization of fluorescently labeled fasciculin-2 to N-AChE-S transfected cells indicated membranal localization. In cultured cell lines, N-AChE-S transfection activated the Tau kinase GSK3, induced Tau hyper-phosphorylation and caused apoptosis. N-AChE-S-induced cell death was suppressible by inhibiting GSK3 or caspases, by enforced overexpression of the anti-apoptotic Bcl2 proteins, or by AChE inhibition or silencing. Moreover, inherent N-AChE-S was upregulated by stressors inducing protein misfolding and calcium imbalances, both characteristic of AD; and in cortical tissues from AD patients, N-AChE-S overexpression coincides with Tau hyper-phosphorylation. CONCLUSIONS: Together, these findings attribute an apoptogenic role to N-AChE-S and outline a potential value to AChE inhibitor therapeutics in early AD.


Subject(s)
Acetylcholinesterase/physiology , Alzheimer Disease/enzymology , Alzheimer Disease/pathology , Apoptosis , Acetylcholinesterase/metabolism , Brain/metabolism , Caspases/metabolism , Cell Membrane/metabolism , Genetic Variation , Glycogen Synthase Kinase 3/metabolism , Humans , Models, Biological , Neurons/metabolism , Phosphorylation , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Cholinergic/metabolism , tau Proteins/genetics , tau Proteins/metabolism
5.
Neurodegener Dis ; 4(2-3): 171-84, 2007.
Article in English | MEDLINE | ID: mdl-17596712

ABSTRACT

BACKGROUND: Peripheral anionic site (PAS) blockade of acetylcholinesterase (AChE) notably affects neuronal activity and cyto-architecture, however, the mechanism(s) involved are incompletely understood. OBJECTIVE: We wished to specify the PAS extracellular effects on specific AChE mRNA splice variants, delineate the consequent cellular remodeling events, and explore the inhibitory effects on interchanging RACK1 interactions. METHODS: We exposed rat hippocampal cultured neurons to BW284C51, the peripheral anionic site inhibitor of AChE, and to the non-selective AChE active site inhibitor, physostigmine for studying the neuronal remodeling of AChE mRNA expression and trafficking. RESULTS: BW284C51 induced overexpression of both AChE splice variants, yet promoted neuritic translocation of the normally rare AChE-R, and retraction of AChE-S mRNA in an antisense-suppressible manner. BW284C51 further caused modest decreases in the expression of the scaffold protein RACK1 (receptor for activated protein kinase betaII), followed by drastic neurite retraction of both RACK1 and the AChE homologue neuroligin1, but not the tubulin-associated MAP2 protein. Accompanying BW284C51 effects involved decreases in the Fyn kinase and membrane insertion of the glutamate receptor NR2B variant and impaired glutamatergic activities of treated cells. Intriguingly, molecular modeling suggested that direct, non-catalytic competition with Fyn binding by the RACK1-interacting AChE-R variant may be involved. CONCLUSIONS: Our findings highlight complex neuronal AChE-R/RACK1 interactions and are compatible with the hypothesis that peripheral site AChE inhibitors induce RACK1-mediated neuronal remodeling, promoting suppressed glutamatergic neurotransmission.


Subject(s)
Acetylcholinesterase/metabolism , Neurons/physiology , Receptors, Cell Surface/metabolism , Acetylcholinesterase/genetics , Alternative Splicing , Animals , Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide/pharmacology , Cells, Cultured , Cholinesterase Inhibitors/pharmacology , Cricetinae , Cricetulus , Embryo, Mammalian , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Excitatory Postsynaptic Potentials/radiation effects , Gene Expression Regulation, Enzymologic/drug effects , Hippocampus/cytology , Models, Molecular , Nerve Tissue Proteins/metabolism , Neurons/cytology , Neurons/drug effects , Patch-Clamp Techniques/methods , Physostigmine/pharmacology , RNA, Messenger/biosynthesis , Rats , Receptors for Activated C Kinase , Receptors, Glutamate/drug effects , Receptors, Glutamate/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods
6.
Proc Natl Acad Sci U S A ; 103(23): 8628-33, 2006 Jun 06.
Article in English | MEDLINE | ID: mdl-16731619

ABSTRACT

In Alzheimer's disease, both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) colocalize with brain fibrils of amyloid-beta (Abeta) peptides, and synaptic AChE-S facilitates fibril formation by association with insoluble Abeta fibrils. Here, we report that human BChE and BSP41, a synthetic peptide derived from the BChE C terminus, inversely associate with the soluble Abeta conformers and delay the onset and decrease the rate of Abeta fibril formation in vitro, at a 1:100 BChE/Abeta molar ratio and in a dose-dependent manner. The corresponding AChE synthetic peptide (ASP)40 peptide, derived from the homologous C terminus of synaptic human (h)AChE-S, failed to significantly affect Abeta fibril formation, attributing the role of enhancing this process to an AChE domain other than the C terminus. Circular dichroism and molecular modeling confirmed that both ASP40 and BChE synthetic peptide (BSP)41 are amphipathic alpha-helices. However, ASP40 shows symmetric amphipathicity, whereas BSP41 presented an aromatic tryptophan residue in the polar side of the C terminus. That this aromatic residue is causally involved in the attenuating effect of BChE was further supported by mutagenesis experiments in which (W8R) BSP41 showed suppressed capacity to attenuate fibril formation. In Alzheimer's disease, BChE may have thus acquired an inverse role to that of AChE by adopting imperfect amphipathic characteristics of its C terminus.


Subject(s)
Amyloid/chemistry , Amyloid/metabolism , Butyrylcholinesterase/metabolism , Acetylcholinesterase/chemistry , Amino Acid Sequence , Amyloid/biosynthesis , Butyrylcholinesterase/chemistry , Conserved Sequence , Humans , Kinetics , Models, Molecular , Molecular Sequence Data , Peptides/chemistry , Solubility , Structure-Activity Relationship
7.
Mol Microbiol ; 49(2): 401-10, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12828638

ABSTRACT

Active protein-disaggregation by a chaperone network composed of ClpB and DnaK + DnaJ + GrpE is essential for the recovery of stress-induced protein aggregates in vitro and in Escherichia coli cells. K-glutamate and glycine-betaine (betaine) naturally accumulate in salt-stressed cells. In addition to providing thermo-protection to native proteins, we found that these osmolytes can strongly and specifically activate ClpB, resulting in an increased efficiency of chaperone-mediated protein disaggregation. Moreover, factors that inhibited the chaperone network by impairing the stability of the ClpB oligomer, such as natural polyamines, dilution, or high salt, were efficiently counteracted by K-glutamate or betaine. The combined protective, counter-negative and net activatory effects of K-glutamate and betaine, allowed protein disaggregation and refolding under heat-shock temperatures that otherwise cause protein aggregation in vitro and in the cell. Mesophilic organisms may thus benefit from a thermotolerant osmolyte-activated chaperone mechanism that can actively rescue protein aggregates, correctly refold and maintain them in a native state under heat-shock conditions.


Subject(s)
Amino Acids, Dicarboxylic/metabolism , Betaine/metabolism , Glycine/metabolism , Molecular Chaperones/metabolism , Adenosine Triphosphate/metabolism , Bacterial Proteins/metabolism , Endopeptidase Clp , Escherichia coli/cytology , Escherichia coli/metabolism , Escherichia coli Proteins/metabolism , HSP40 Heat-Shock Proteins , HSP70 Heat-Shock Proteins/metabolism , Heat-Shock Proteins/metabolism , Malate Dehydrogenase/metabolism , Protein Denaturation , Protein Folding , Salts/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL